A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-09-10) →
What happened
BL Pharmtech disclosed an acquisition, worth US$699K.
For context, this deal is worth about 5.8% of the company's own total assets.
| Target | Disclosed |
|---|---|
| Deal value | US$699K |
| vs. company assets | 5.8% |
| Filed | 2026-07-13, Decision to acquire shares/equity in another company |
| Source | DART rcept 20260713900414 → open original filing |
Versions of this filing
- 2026-07-13Original (this page)
- 2026-09-10Amendment 1
Source: DART. Information only, not investment advice.
